GlobeImmune, Inc. (GBIM)
Develops cancer and infection vaccines using personalized immune-boosting technology platforms.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
GBIM is trading at its 52-week high with price above both its 50- and 200-day moving averages, showing upward trend positioning. The StockGlow score leans bullish at 88/100. Analyst coverage appears thin or unavailable for this micro-cap stock.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$575
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—